论文部分内容阅读
目的观察扶正消积汤联合化疗治疗中晚期结肠癌的临床效果。方法选取医院收治的中晚期结肠癌患者120例为研究对象,随机分为观察组和对照组,每组60例。观察组采用扶正消积汤联合化疗,对照组采用单一化疗,观察2组患者的近期疗效和免疫功能情况。结果观察组近期疗效总有效率为81.7%,高于对照组的65.0%(P<0.05);观察组CD4~+水平(35.8±2.3)%、CD8~+水平(24.3±2.1)%、CD4~+/CD8~+值(1.5±0.6),均高于对照组的CD4~+水平(27.2±2.6)%、CD8~+水平(17.5±2.4)%、CD4~+/CD8~+值(1.2±0.3),差异均有统计学意义(P<0.01)。结论扶正消积汤联合化疗治疗中晚期结肠癌疗效确切,值得临床推广应用。
Objective To observe the clinical effect of Fuzheng Xiaoji Decoction combined with chemotherapy in the treatment of advanced colon cancer. Methods A total of 120 patients with advanced colon cancer who were treated in hospital were selected as study subjects and randomly divided into observation group and control group with 60 cases in each group. The observation group was treated with Fuzheng Xiaoji Decoction combined with chemotherapy, and the control group with single chemotherapy. The curative effect and immune function of the two groups were observed. Results The total effective rate in the observation group was 81.7%, which was higher than that in the control group (65.0%, P <0.05). The CD4 ~ + level in the observation group was 35.8 ± 2.3%, the level of CD8 + was 24.3 ± 2.1% CD4 + / CD8 + values (1.5 ± 0.6) in control group were significantly higher than those in control group (27.2 ± 2.6)%, CD8 + 1.2 ± 0.3), the differences were statistically significant (P <0.01). Conclusion Fuzheng Xiaoji Decoction combined with chemotherapy for the treatment of advanced colon cancer is effective and worthy of clinical application.